$6.925
-0.227 (-3.28%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RGNX Prediction & Forecast by Similar Chart Analysis
Alphio's RGNX stock price prediction model matches the current Regenxbio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.93 (+0.01%). The 1-week path is $6.39 (-7.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Regenxbio Inc Stock?
Regenxbio Inc (RGNX) is a good buy right now due to its recent positive developments in clinical trials and strong insider buying activity. The current price is $6.925, significantly lower than the analyst price targets of $21 and $22, indicating substantial upside potential. Additionally, the company has a gross margin of 99.04% in Q2 2026, showcasing strong profitability potential despite recent volatility. The main risk is the clinical hold on RGX-121, which has led to a downgrade in some analyst targets, but the overall sentiment remains bullish due to the promising RGX-202 trial results.
RGNX stock price ended at $6.93 on Friday, after losing -3.28%
Regenxbio Inc (RGNX) last closed at $6.925, losing -3.28%. These facts feed the 1-day and 1-week RGNX price prediction above.
Analyst Consensus
Regenxbio Inc (RGNX): 5 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Regenxbio Inc (RGNX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RGNX, ranked by similarity.
Seasonality analysis for RGNX
Historically the probability of a positive October return for RGNX is 39.66%. December offers the highest probability of a positive month at 51.16%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RGNX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $18.85 | $19.83 | $24.04 | +186.34% |
| Nov 2026 | $11.03 | $16.25 | $21.08 | +134.63% |
| Dec 2026 | $11.89 | $17.37 | $19.04 | +150.85% |
In 2026, Regenxbio Inc (RGNX) is projected to range from $11.03 to $24.04.
Regenxbio Inc 2026 monthly forecast
In Oct 2026, Regenxbio Inc is projected to average $19.83, with a low of $18.85 and high of $24.04.
In Nov 2026, Regenxbio Inc is projected to average $16.25, with a low of $11.03 and high of $21.08.
In Dec 2026, Regenxbio Inc is projected to average $17.37, with a low of $11.89 and high of $19.04.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.